All Stories

  1. Anthropometric and Demographic Features Affect the Interpretation of Cerebrospinal Fluid Biomarkers in Patients with Different Dementia Syndromes and Cognitively Healthy Adults
  2. Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease
  3. Neuropsychiatric feature profiles of patients with Lewy body dementia
  4. Sleep deprivation changes thimet oligopeptidase (THOP1) expression and activity in rat brain
  5. Plasma kallikrein‐kinin system contributes to peripheral inflammation in temporal lobe epilepsy
  6. Renal denervation reduces sympathetic overactivation, brain oxidative stress, and renal injury in rats with renovascular hypertension independent of its effects on reducing blood pressure
  7. Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison
  8. Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer’s Disease
  9. Protective Role of UCP2 in Oxidative Stress and Apoptosis during the Silent Phase of an Experimental Model of Epilepsy Induced by Pilocarpine
  10. Neurochemical Changes and c-Fos Mapping in the Brain after Carisbamate Treatment of Rats Subjected to Lithium–Pilocarpine-Induced Status Epilepticus
  11. Maternal seizures can affect the brain developing of offspring
  12. Methadone Increases and Prolongs Detomidine-Induced Arterial Hypertension in Horses, but These Effects Are Not Mediated by Increased Plasma Concentrations of Arginine Vasopressin or Serum Concentrations of Catecholamines
  13. High serum levels of proinflammatory markers during epileptogenesis. Can omega-3 fatty acid administration reduce this process?
  14. Indomethacin can downregulate the levels of inflammatory mediators in the hippocampus of rats submitted to pilocarpine-induced status epilepticus
  15. Lovastatin decreases the synthesis of inflammatory mediators during epileptogenesis in the hippocampus of rats submitted to pilocarpine-induced epilepsy
  16. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions
  17. Expression and activity of thimet oligopeptidase (TOP) are modified in the hippocampus of subjects with temporal lobe epilepsy (TLE)
  18. Lovastatin and sudden unexpected death in epilepsy: A matter for debate
  19. Exercise-induced hippocampal anti-inflammatory response in aged rats
  20. Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties
  21. Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms
  22. The levels of renin–angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy
  23. Interleukin-6 bares a dark side in sudden unexpected death in epilepsy
  24. Consequences of pilocarpine-induced status epilepticus in immunodeficient mice
  25. Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy
  26. Masruha et al. reply
  27. Stress during development alters anxiety-like behavior and hippocampal neurotransmission in male and female rats
  28. Neuroglobin is up‐regulated in the cerebellum of pups exposed to maternal epileptic seizures
  29. Melatonin administration after pilocarpine-induced status epilepticus: A new way to prevent or attenuate postlesion epilepsy?
  30. Kallikrein 1 is overexpressed by astrocytes in the hippocampus of patients with refractory temporal lobe epilepsy, associated with hippocampal sclerosis
  31. Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats
  32. Relationship between fluid-attenuated inversion-recovery (FLAIR) signal intensity and inflammatory mediator's levels in the hippocampus of patients with temporal lobe epilepsy and mesial temporal sclerosis
  33. Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus
  34. Malnutrition in Infancy as a Susceptibility Factor for Temporal Lobe Epilepsy in Adulthood Induced by the Pilocarpine Experimental Model
  35. Spontaneous periodic hypothermia and hyperhidrosis: a possibly novel cerebral neurotransmitter disorder
  36. Early exercise promotes positive hippocampal plasticity and improves spatial memory in the adult life of rats
  37. Physical exercise in adolescence changes CB1 cannabinoid receptor expression in the rat brain
  38. Seizures during pregnancy modify the development of hippocampal interneurons of the offspring
  39. Hippocampal expression and distribution of CB1 receptors in the Amazonian rodent Proechimys: An animal model of resistance to epilepsy
  40. Behavioral evaluation of adult rats exposed in utero to maternal epileptic seizures
  41. 94. Melatonin levels are decreased in rats with epilepsy induced by pilocarpine
  42. Akt pathway activation and increased neuropeptide Y mRNA expression in the rat hippocampus: Implications for seizure blockade
  43. Pathophysiological Aspects of Temporal Lobe Epilepsy and the Role of P2X Receptors
  44. Rasmussen Encephalitis: longterm outcome after surgery
  45. The pilocarpine model of epilepsy: what have we learned?
  46. Nestin down-regulation of cortical radial glia is delayed in rats submitted to recurrent status epilepticus during early postnatal life
  47. Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin
  48. Rasmussen encephalitis: long-term outcome after surgery
  49. Neurogenesis induced by seizures in the dentate gyrus is not related to mossy fiber sprouting but is age dependent in developing rats
  50. Serotonin depletion effects on the pilocarpine model of epilepsy
  51. Effect of hormonal replacement therapy in the hippocampus of ovariectomized epileptic female rats using the pilocarpine experimental model
  52. The renin‐angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis
  53. Chondroitin sulfate and kallikrein in saliva: Markers for glossodynia
  54. Idiopathic Intracranial Hypertension With and Without Papilloedema in a Consecutive Series of Patients With Chronic Migraine
  55. Bone marrow cells are able to increase vessels number during repair of sciatic nerve lesion
  56. Kinin B1 receptors facilitate the development of temporal lobe epilepsy in mice
  57. Cardiovascular protective effect of melatonin in sudden unexpected death in epilepsy: A hypothesis
  58. Glutamate Levels in Cerebrospinal Fluid and Triptans Overuse in Chronic Migraine
  59. Effects of different types of physical exercise on the staining of parvalbumin-positive neurons in the hippocampal formation of rats with epilepsy
  60. Estudo comparativo entre enxerto autógeno e enxerto muscular coberto com tubo de veia autógeno em nervos tibiais de ratos wistar, utilizando o fluoro-gold® como marcador neuronal
  61. Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy
  62. Effect of aerobic physical exercise in pinealectomized animals submitted to the pilocarpine model of epilepsy
  63. Effect of glycemic state in rats submitted to status epilepticus during development
  64. Efeito neuroprotetor da melatonina e N-acetilserotonina na epileptogênese e no controle de crises em animais submetidos ao modelo da pilocarpina
  65. Cerebrospinal fluid GABA levels in chronic migraine with and without depression
  66. Investigation of mitochondrial involvement in the experimental model of epilepsy induced by pilocarpine
  67. Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats
  68. Expression of nestin in the hippocampal formation of rats submitted to the pilocarpine model of epilepsy
  69. Status epilepticus induced by pilocarpine and Ca2+ transport by microsome in the hippocampus of rats
  70. Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons
  71. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy
  72. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy
  73. Pilocarpine-induced status epilepticus increases glutamate release in rat hippocampal synaptosomes
  74. Levels of the synaptic protein X11 alpha/mint1 are increased in hippocampus of rats with epilepsy
  75. Mesangial cells are able to produce catecholamines in vitro
  76. Glycosaminoglycan levels and proteoglycan expression are altered in the hippocampus of patients with mesial temporal lobe epilepsy
  77. Extracellular Matrix Components are Altered in the Hippocampus, Cortex, and Cerebrospinal Fluid of Patients with Mesial Temporal Lobe Epilepsy
  78. Evidence That ATP Participates in the Pathophysiology of Pilocarpine-Induced Temporal Lobe Epilepsy: A Fluorimetric, Immunohistochemical, and Western Blot Studies
  79. Amino acid and monoamine alterations in the cerebral cortex and hippocampus of mice submitted to ricinine-induced seizures
  80. Castration in female rats modifies the development of the pilocarpine model of epilepsy
  81. Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats
  82. Catecholamine response to exercise in individuals with different levels of paraplegia
  83. Selective alterations of glycosaminoglycans synthesis and proteoglycan expression in rat cortex and hippocampus in pilocarpine-induced epilepsy
  84. Growth-associated phosphoprotein expression is increased in the supragranular regions of the dentate gyrus following pilocarpine-induced seizures in rats
  85. Mitogen-activated protein kinase is increased in the limbic structures of the rat brain during the early stages of status epilepticus
  86. Tyrosine phosphorylation is increased in the rat hippocampus during the status epilepticus induced by pilocarpine
  87. Monoamine responses to acute and chronic aerobic exercise in normotensive and hypertensive subjects
  88. Monoamines and their metabolites in cerebrospinal fluid and temporal cortex of epileptic patients
  89. Na+K+ ATPase activity in the rat hippocampus: A study in the pilocarpine model of epilepsy
  90. Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy
  91. Spontaneous Recurrent Seizures in Rats: Amino Acid and Monoamine Determination in the Hippocampus
  92. Rat liver kininase, a serine peptidase
  93. Inactivation of kinins by chymotrypsin